tiprankstipranks
Advertisement
Advertisement

CVRX Stock Latest News

CVRx announces Devoted Health Medicare Advantage coverage policy for Barostim
The FlyCVRx announces Devoted Health Medicare Advantage coverage policy for Barostim
11d ago
CVRX
Jorey Chernett urges CVRx board to commence formal sales process
PremiumThe Fly
Jorey Chernett urges CVRx board to commence formal sales process
11d ago
CVRX
CVRx Earnings Call Balances Growth With New Risks
PremiumCompany Announcements
CVRx Earnings Call Balances Growth With New Risks
17d ago
CVRX
CVRx price target lowered to $5 from $13 at Cantor Fitzgerald
PremiumThe Fly
CVRx price target lowered to $5 from $13 at Cantor Fitzgerald
18d ago
CVRX
Analyst Reaffirms Buy on CVRx, Maintains Unchanged $5 Price Target Amid Improving Reimbursement and Growth Outlook
PremiumRatings
Analyst Reaffirms Buy on CVRx, Maintains Unchanged $5 Price Target Amid Improving Reimbursement and Growth Outlook
23d ago
CVRX
CVRx chief revenue officer Robert John to depart
PremiumThe FlyCVRx chief revenue officer Robert John to depart
24d ago
CVRX
CVRx replaces chief revenue officer amid sales transition
Premium
Company Announcements
CVRx replaces chief revenue officer amid sales transition
24d ago
8K
CVRX
CVRx downgraded to Hold from Buy at Lake Street
Premium
The Fly
CVRx downgraded to Hold from Buy at Lake Street
28d ago
CVRX
CVRx downgraded to Hold from Buy at Craig-Hallum
PremiumThe Fly
CVRx downgraded to Hold from Buy at Craig-Hallum
28d ago
CVRX
CVRx price target lowered to $5 from $10 at Canaccord
PremiumThe Fly
CVRx price target lowered to $5 from $10 at Canaccord
28d ago
CVRX
O’Brien Maintains Hold on CVRx, Cuts Price Target from $12 to $4 Amid Execution Challenges and Trimmed Outlook
PremiumRatings
O’Brien Maintains Hold on CVRx, Cuts Price Target from $12 to $4 Amid Execution Challenges and Trimmed Outlook
28d ago
CVRX
CVRx downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
CVRx downgraded to Neutral from Overweight at Piper Sandler
28d ago
CVRX
CVRx reports Q2 EPS (53c), consensus (52c)
PremiumThe FlyCVRx reports Q2 EPS (53c), consensus (52c)
29d ago
CVRX
CVRx cuts FY26 revenue view to $58M-$60M from $63M-$67M, consensus $65.28M
Premium
The Fly
CVRx cuts FY26 revenue view to $58M-$60M from $63M-$67M, consensus $65.28M
29d ago
CVRX
CVRx sees Q3 revenue $13.5M-$14.5M, consensus $16.84M
Premium
The Fly
CVRx sees Q3 revenue $13.5M-$14.5M, consensus $16.84M
29d ago
CVRX
CVRx’s REBALANCE Registry Update: What the Termination Means for Barostim Investors
PremiumCompany Announcements
CVRx’s REBALANCE Registry Update: What the Termination Means for Barostim Investors
1M ago
CVRX
CVRx CFO Announces Resignation and Leadership Transition Plan
PremiumCompany Announcements
CVRx CFO Announces Resignation and Leadership Transition Plan
3M ago
8K
CVRX
CVRx CFO Jared Oasheim to step down
PremiumThe Fly
CVRx CFO Jared Oasheim to step down
3M ago
CVRX
CVRx Shareholders Reelect Directors and Ratify Auditor
PremiumCompany Announcements
CVRx Shareholders Reelect Directors and Ratify Auditor
3M ago
8K
CVRX
CVRx announces Humana Medicare Advantage coverage policy for Barostim therapy
PremiumThe FlyCVRx announces Humana Medicare Advantage coverage policy for Barostim therapy
4M ago
HUM
CVRX
CVRx Earnings Call Highlights Growth Amid Ongoing Losses
Premium
Company Announcements
CVRx Earnings Call Highlights Growth Amid Ongoing Losses
4M ago
CVRX
CVRx reports Q1 EPS (50c), consensus (50c)
Premium
The Fly
CVRx reports Q1 EPS (50c), consensus (50c)
4M ago
CVRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >